Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Hematology

Recognizing the Symptoms and Progression of BPDCN

At a Glance

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive blood cancer that usually appears first as unhealing, bruise-like skin lesions. As it progresses, it spreads to the bone marrow, lymph nodes, and central nervous system, causing fatigue, easy bruising, and lowered immunity.

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is often called a “great imitator” because its symptoms frequently look like common skin conditions or other types of blood cancer. Understanding how this disease presents and moves through the body can help you navigate the diagnostic process and prepare for treatment.

The “Skin-First” Presentation

For about 80% to 90% of patients, the first sign of BPDCN appears on the skin [1][2]. Because these signs are so visible, patients often visit a dermatologist before an oncologist. The skin lesions can take several forms:

  • Nodules: Firm, raised bumps that can be reddish, purple, or flesh-colored [3][4].
  • Bruise-like Patches: Flat, purple or brownish areas that look like a traumatic injury or a hematoma (a collection of blood) but do not heal like a normal bruise [4][2].
  • Macules and Plaques: Discolored flat spots (macules) or slightly raised, thickened patches of skin (plaques) [5][2].

These lesions may appear anywhere on the body, can be single or multiple, and occasionally become ulcerated (open sores) [6][7]. Because they can look like a simple rash or an inflammatory condition, the diagnosis is frequently delayed while patients try topical creams or other treatments that do not work [8][9].

While the vast majority of patients present with skin symptoms, about 10% to 20% do not have any skin involvement. For these individuals, the first signs are typically related to unexplained bone marrow failure or swollen lymph nodes [8].

Progression to Systemic Disease

While BPDCN often starts in the skin, it is a systemic (whole-body) blood cancer. It typically spreads through the blood and lymphatic system to other organs [1].

  • Lymph Nodes and Spleen: The cancer cells often gather in the lymph nodes (causing swelling or lymphadenopathy) and the spleen (causing splenomegaly, which might feel like fullness or pain in the upper left side of your abdomen) [1][10].
  • Bone Marrow: As the disease progresses, BPDCN cells invade the bone marrow, the “factory” where your blood is made [11][12].
  • Central Nervous System (CNS): BPDCN has a tendency to travel to the brain and spinal cord. Even if you have no symptoms like headaches or confusion, doctors often check the spinal fluid to ensure the cancer is not hiding there [13][14].

Symptoms of Bone Marrow Involvement

When BPDCN cells take over the bone marrow, they crowd out the healthy cells that your body needs to function. This leads to pancytopenia (low levels of all three major blood cell types), which causes distinct symptoms [11][12]:

Low Cell Type Medical Term Resulting Symptoms
Red Blood Cells Anemia Extreme fatigue, shortness of breath, and pale skin [12].
Platelets Thrombocytopenia Easy bruising, nosebleeds, or petechiae (tiny purple or red dots on the skin) [15][12].
White Blood Cells Neutropenia Increased risk of serious infections and fevers [11].

The combination of persistent skin lesions and “crashing” blood counts is often what finally leads doctors to perform the specialized tests—like a bone marrow biopsy and detailed flow cytometry—required to confirm BPDCN [16][17].

Common questions in this guide

What are the early skin signs of BPDCN?
For most patients, the first sign of BPDCN appears on the skin. These lesions can look like firm reddish or purple bumps, discolored flat spots, or bruise-like patches that do not heal normally like a typical bruise would.
Does BPDCN spread to other parts of the body?
Yes. Although it often shows up on the skin first, BPDCN is a systemic blood cancer. It typically spreads through the bloodstream and lymphatic system into the lymph nodes, spleen, bone marrow, and the central nervous system.
Why does BPDCN cause severe fatigue and easy bruising?
When BPDCN cancer cells invade the bone marrow, they crowd out the healthy cells that produce your blood. This causes a drop in red blood cells leading to extreme fatigue, and a drop in platelets which causes easy bruising and tiny red or purple skin dots.
Why is my doctor checking my spinal fluid if I don't have headaches?
Because BPDCN has a strong tendency to travel to the brain and spinal cord, doctors routinely check the spinal fluid. This test helps ensure the cancer is not hiding in the central nervous system, even if you do not have any noticeable neurological symptoms.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific results from my skin biopsy led to the BPDCN diagnosis versus another condition?
  2. 2.What stage is my BPDCN? Has it spread to my bone marrow, lymph nodes, or spleen?
  3. 3.Are you planning to check my spinal fluid (lumbar puncture) for cancer cells even if I don't have neurological symptoms?
  4. 4.Based on my current blood counts, do I need transfusions or medications to prevent infections right now?
  5. 5.How do we monitor if the skin lesions are responding to the systemic treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    [Clinical characteristics of 6 patients with blastic plasmacytoid dendritic cell neoplasm].

    Han X, Ouyang MQ, Pei Q, et al.

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2017; (38(8)):700-705 doi:10.3760/cma.j.issn.0253-2727.2017.08.010.

    PMID: 28954350
  2. 2

    Petechiae and a Persistent Violaceous Nodule: A Presentation of Blastic Plasmacytoid Dendritic Cell Neoplasm to Dermatology.

    Anzelc M, Druskovich C, Cusick A, Franklin M

    Case reports in dermatological medicine 2025; (2025()):8628105 doi:10.1155/crdm/8628105.

    PMID: 40135229
  3. 3

    A woman with rare blastic plasmacytoid dendritic cell neoplasm on the face.

    Huang YY, Liu YR, Li K, et al.

    Oral surgery, oral medicine, oral pathology and oral radiology 2016; (121(1)):e16-8.

    PMID: 26159087
  4. 4

    Blastic plasmacytoid dendritic cell neoplasm with response to pralatrexate.

    Sato S, Tanaka E, Tamai Y

    Annals of hematology 2019; (98(3)):801-803 doi:10.1007/s00277-019-03611-3.

    PMID: 30652209
  5. 5

    BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM --A RAPIDLY EVOLVING ENTITY. CASE REPORT.

    Andrese E, Solovăstru LG, Dimofte G, et al.

    Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 2015; (119(2)):379-83.

    PMID: 26204640
  6. 6

    Childhood Blastic Plasmacytoid Dendritic Cell Neoplasm Mimicking Acute Rheumatic Fever: Report of an Unusual Clinical Presentation and Review of Literature.

    Rajkumari BD, Munikoty V, Sreedharanunni S, et al.

    Journal of pediatric hematology/oncology 2018; (40(5)):e327-e329 doi:10.1097/MPH.0000000000000951.

    PMID: 28859047
  7. 7

    Cutaneous Manifestation of a Rare Haematological Malignancy: A Case Report of the Presentation, Diagnosis, and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm.

    Hassan SL, Chatha DE

    Cureus 2025; (17(7)):e87604 doi:10.7759/cureus.87604.

    PMID: 40786289
  8. 8

    Blastic Plasmacytoid Dendritic Cell Neoplasm: Clinical Presentation and Diagnosis.

    Deconinck E, Petrella T, Garnache Ottou F

    Hematology/oncology clinics of North America 2020; (34(3)):491-500 doi:10.1016/j.hoc.2020.01.010.

    PMID: 32336414
  9. 9

    An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases.

    Ohgami RS, Aung PP, Gru AA, et al.

    Archives of pathology & laboratory medicine 2023; (147(7)):837-846 doi:10.5858/arpa.2021-0612-RA.

    PMID: 36170615
  10. 10

    A Very Rare Type of Leukemia in a Young Pediatric Patient Treated With Hematopoietic Stem Cell Transplantation: Blastic Plasmacytoid Dendritic Cell Neoplasm.

    Tekkeşin F, Asarcikli F, Yildirim ÜM, et al.

    Journal of pediatric hematology/oncology 2021; (43(2)):e288-e291 doi:10.1097/MPH.0000000000001999.

    PMID: 33235146
  11. 11

    Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.

    Pemmaraju N, Lane AA, Sweet KL, et al.

    The New England journal of medicine 2019; (380(17)):1628-1637 doi:10.1056/NEJMoa1815105.

    PMID: 31018069
  12. 12

    Spontaneous Regression of Blastic Plasmacytoid Dendritic Cell Neoplasm Following Sepsis by Serratia marcescens: A Case Report and Literature Review.

    Suzuki A, Abe S, Koyama K, et al.

    Internal medicine (Tokyo, Japan) 2021; (60(6)):927-933 doi:10.2169/internalmedicine.5820-20.

    PMID: 33716255
  13. 13

    Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD.

    Pemmaraju N, Wilson NR, Garcia-Manero G, et al.

    Blood advances 2022; (6(10)):3027-3035 doi:10.1182/bloodadvances.2021006645.

    PMID: 35061885
  14. 14

    A 31-year-old male with a plasmacytoid dendritic blast cell neoplasm.

    Hernández DC, Rueda DÁ, Rapan L, et al.

    Ecancermedicalscience 2024; (18()):1806 doi:10.3332/ecancer.2024.1806.

    PMID: 39816397
  15. 15

    Blastic plasmacytoid dendritic cell neoplasm.

    Pemmaraju N

    Clinical advances in hematology & oncology : H&O 2016; (14(4)):220-2.

    PMID: 27166602
  16. 16

    Blastic Plasmacytoid Dendritic Cell Neoplasm; A Report of Three Cases.

    Safaei A, Monabati A, Mokhtari M, et al.

    Iranian journal of medical sciences 2019; (44(1)):74-78.

    PMID: 30666080
  17. 17

    Diagnostic approach to blastic plasmacytoid dendritic cell neoplasm: historical perspectives and current understanding.

    Sakamoto K, Takeuchi K

    Journal of clinical and experimental hematopathology : JCEH 2025; (65(1)):1-16 doi:10.3960/jslrt.24069.

    PMID: 40159280

This page provides information on BPDCN symptoms and disease progression for educational purposes only. Always consult your hematologist-oncologist or dermatologist for a proper medical evaluation and diagnosis.

Get notified when new evidence is published on Blastic plasmacytoid dendritic cell neoplasm.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.